NEW YORK, Sept. 02, 2023 (GLOBE NEWSWIRE) --
RPT Realty (NYSE: RPT)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of RPT to Kimco Realty for 0.6049 of a newly-issued Kimco Realty share for each share of RPT common stock owned.
If you are a RPT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Hersha Hospitality Trust (NYSE: HT)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of HT to KSL Capital Partners, LLC for $10.00 per share in cash for each share of HT common stock owned.
If you are a HT investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Summit Financial Group, Inc. (NASDAQ: SMMF)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of SMMF and Burke & Herbert Financial Services Corporation. Under the terms of the proposed transaction, SMMF shareholders will have the right to receive 0.5043 shares of Burke & Herbert Financial Services Corporation for each share of SMMF common stock owned.
If you are a SMMF investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
Acer Therapeutics, Inc. (NASDAQ: ACER)
Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of ACER to Zevra Therapeutics, Inc. for 0.121 of a share of Zevra Therapeutics, Inc. for each share of ACER common stock owned. In addition, ACER stockholders would receive non-transferable Contingent Value Rights entitling them to receive up to $34 million in cash upon the achievement of certain commercial milestones for OLPRUVA, and up to an additional $42 million in cash upon the achievement of certain regulatory milestones for OLPRUVA and EDSIVO.
If you are an ACER investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@lifshitzlaw.com.
ATTORNEY ADVERTISING.© 2023 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact:
Joshua M. Lifshitz, Esq.
Lifshitz Law PLLC
Phone: 516-493-9780
Facsimile: 516-280-7376
Email: info@lifshitzlaw.com
